GASTROINTESTINAL CANCER
Clinical trials for GASTROINTESTINAL CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL CANCER trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough gut cancers: first human trial launches
Disease control Not yet recruitingThis study tests a new drug called DB-1324 in people with advanced stomach, bowel, or other gastrointestinal cancers that have stopped responding to standard treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. About 127 part…
Matched conditions: GASTROINTESTINAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
Could existing melanoma drugs work for other rare cancers? new trial aims to find out.
Disease control Not yet recruitingThis trial tests two approved drugs, dabrafenib and trametinib, in people with rare cancers that have a BRAF V600 mutation. The drugs are already used for melanoma and lung cancer. About 30 adults, children, and teens will take part. The goal is to see if the drugs shrink tumors …
Matched conditions: GASTROINTESTINAL CANCER
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Nutritional drink may cut chemo side effects in advanced GI cancers
Symptom relief Not yet recruitingThis study tests whether a high-calorie, high-protein nutritional drink with added immune-supporting nutrients can lower the risk of serious side effects in people with advanced gastrointestinal cancers receiving their first systemic treatment. About 88 participants will be rando…
Matched conditions: GASTROINTESTINAL CANCER
Phase: NA • Sponsor: IRCCS San Raffaele • Aim: Symptom relief
Last updated May 17, 2026 07:04 UTC
-
Could zapping the spleen fix Chemo's side effect?
Symptom relief Not yet recruitingThis study tests a new use of targeted radiation (SIRT) to the spleen in 18 adults with gastrointestinal cancer whose platelet counts drop dangerously low after chemotherapy. The goal is to find a safe dose that raises platelets and reduces bleeding risk. It is an early-stage pil…
Matched conditions: GASTROINTESTINAL CANCER
Phase: NA • Sponsor: Centre Georges Francois Leclerc • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC
-
New study aims to predict which cancer patients struggle most with eating
Knowledge-focused Not yet recruitingThis study looks at how cancer and its treatments change the way patients experience food, including taste, appetite, and enjoyment of eating. Researchers will survey 180 adults with breast, head and neck, gynecologic, gastrointestinal, or lung cancer to understand which factors …
Matched conditions: GASTROINTESTINAL CANCER
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC